| http://www.w3.org/ns/prov#value | - Eli Lilly (Prozac/fluoxetine), Forest Laboratories - formerly Parke-Davis (Celexa/Citalopram) and (in the SNRI field) Wyeth (Effexor/venlafaxine) would all, most likely, be willing to cooperate with such an initiative when there is a greater chance that the more cost effective option is another of their products.
|
